| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790135 | Urologic Oncology: Seminars and Original Investigations | 2018 | 14 Pages |
Abstract
Our data suggest that reduced expression of PBRM1 and VHL is correlated with an increased tumor aggressiveness. Low VHL expression was identified as a risk factor for worse patient overall survival, independently from PBRM1 expression pattern.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Anica M.D., Hans Ph.D., Burkhard Ph.D., Mumtaz Ph.D., Tom Florian M.D., Ph.D., Martin M.D., Ph.D., Andreas M.D., Ph.D., Andreas M.D., Ph.D., Ergin M.D.,